Page last updated: 2024-09-05

sb 203580 and Leukemia, Plasmacytic

sb 203580 has been researched along with Leukemia, Plasmacytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdulahad, WH; Bos, NA; Guikema, JE; Hovenga, S; Vellenga, E	1

Other Studies

1 other study(ies) available for sb 203580 and Leukemia, Plasmacytic

Article	Year
CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinases. British journal of haematology, 2004, Volume: 124, Issue:3 Topics: Apoptosis; Blotting, Western; Butadienes; Dexamethasone; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Glucocorticoids; Humans; Imidazoles; Leukemia, Plasma Cell; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Necrosis Factor Receptor Superfamily, Member 7	2004

Article

Year

CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinases.

British journal of haematology, 2004, Volume: 124, Issue:3

Topics: Apoptosis; Blotting, Western; Butadienes; Dexamethasone; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Glucocorticoids; Humans; Imidazoles; Leukemia, Plasma Cell; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Necrosis Factor Receptor Superfamily, Member 7

2004